INHIBIKASE THERAPEUTICS ANNOUNCES CLOSING OF UP TO $275 MILLION FINANCING AND ADVANCEMENT OF IKT-001PRO INTO A LATE STAGE CLINICAL TRIAL IN PULMONARY ARTERIAL HYPERTENSION

Reuters · 10/21 13:05

Please log in to view news